Korean guidelines for the prevention of venous thromboembolism.
This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently, no nation-wide data on the incidence of VTE exist, and randomized controlled trials aiming at the prevention of VTE in Korea have yielded few results. Therefore, these guidelines were based on the second edition of the Japanese Guidelines for the Prevention of VTE and the eighth edition of the American College of Chest Physicians (ACCP) Evidenced-Based Clinical Practice Guidelines. These guidelines establish low-, moderate-, and high-risk groups, and recommend appropriate thromboprophylaxis for each group.
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Soo-Mee
SM
Bang
Moon Ju
MJ
Jang
Doyeun
D
Oh
Yeo-Kyeoung
YK
Kim
In Ho
IH
Kim
Sung-Soo
SS
Yoon
Hwi-Joong
HJ
Yoon
Chul-Soo
CS
Kim
Seonyang
S
Park
D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use; D056910:Republic of Korea; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000517:prevention & control* / Q000601:surgery / Q000628:therapy; D014859:Warfarin / Q000627:therapeutic use
D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D014859:Warfarin; D000077425:Fondaparinux